Celsius Holdings, Inc. Common Stock
CELH
$27.75
-7.53%
Celsius Holdings operates in the energy drink subsegment of the global non-alcoholic beverage market, owning and marketing brands such as Celsius, Alani Nu, and Rockstar Energy. The company has established itself as a high-growth disruptor in the category, leveraging a capital-light model that outsources manufacturing and distribution, most notably through a strategic partnership with PepsiCo. The current investor narrative is dominated by the company's transformation into a multi-brand platform following the Alani Nu acquisition, which is seen as a key driver for sustaining growth amidst intensifying competition and questions about the core brand's maturity, as reflected in recent news debating its valuation and execution risks after a significant price decline.…
CELH
Celsius Holdings, Inc. Common Stock
$27.75
Related headlines
Investment Opinion: Should I buy CELH Today?
Rating: Hold. The core thesis is that CELH is a high-risk, high-potential turnaround story caught between severe technical damage and promising fundamental catalysts, making it unsuitable for new capital until earnings visibility improves.
Supporting this view are several conflicting data points: the forward P/E of 16.4x suggests the market expects a dramatic profit recovery, yet the trailing P/E of 99.6x and PS ratio of 4.28x indicate a premium valuation that demands perfection. Q4 revenue growth of 117% YoY is impressive, but sequential growth was flat, and bottom-line execution remains wildly inconsistent, with a net loss in Q3 preceding the Q4 profit. While institutional analysts like Deutsche Bank maintain Buy ratings, the limited coverage (5 analysts) and lack of a consensus price target contribute to volatility and uncertain price discovery.
The two biggest risks that could invalidate a future Buy thesis are 1) a failure to achieve the projected $2.57 EPS, leading to forward multiple expansion, and 2) a continuation of poor cash conversion, straining the balance sheet. This Hold rating would upgrade to Buy if the stock stabilizes above key support ($27.66) and the company reports two consecutive quarters of profitable growth with positive operating cash flow. It would downgrade to Sell if revenue growth decelerates below 50% YoY or if the forward P/E expands above 25x due to earnings misses. Relative to its own battered history and the growth it promises, the stock is fairly valued for the substantial risk it carries.
Sign up to view all
CELH 12-Month Price Forecast
CELH presents a classic 'show me' story. The potential is undeniable, with a transformative acquisition and a powerful distribution partner setting the stage for massive earnings growth. However, the stock's violent decline and erratic financials have rightfully shattered investor trust. The neutral stance reflects the high probability (50%) of a messy, volatile base-case outcome where the company grows but fails to inspire a sustained rally. Confidence is medium because the key variable—consistent profitability—is entirely unproven. The stance would upgrade to bullish on evidence of two consecutive clean quarters with strong cash flow. It would turn bearish if the stock breaks $27.66 support on high volume, signaling the breakdown is not over.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Celsius Holdings, Inc. Common Stock's 12-month outlook, with a consensus price target around $36.08 and implied upside of +30.0% versus the current price.
Average Target
$36.08
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$22 - $36
Analyst target range
Analyst coverage appears limited, with data indicating only 5 analysts providing estimates for revenue and EPS, but no consensus price target or recommendation breakdown is provided in the dataset, suggesting insufficient public analyst coverage to form a traditional consensus view. The lack of a clear target range and the minimal number of analysts imply this stock may have less institutional research coverage, which can contribute to higher volatility and less efficient price discovery; however, recent institutional rating actions show a pattern of reiterated Buy or Overweight ratings from firms like Deutsche Bank, Needham, and JP Morgan in early 2026, indicating maintained bullish sentiment among those who do cover it, despite the stock's severe technical breakdown.
Bulls vs Bears: CELH Investment Factors
The evidence currently tilts bearish, driven by the stock's severe technical breakdown, sky-high trailing valuation, and demonstrably volatile earnings. The bull case rests almost entirely on the successful realization of massive forward earnings growth (EPS from $0.01 to $2.57) and the strategic benefits of the Alani Nu acquisition and PepsiCo partnership. The single most important tension in the investment debate is the market's expectation of a near-term profitability miracle (forward P/E of 16.4x) versus the company's recent history of erratic earnings and cash flow challenges. The resolution of this tension—whether CELH can deliver consistent, high-quality profits—will determine the stock's direction.
Bullish
- Massive Forward Earnings Growth Priced In: The forward P/E of 16.4x is dramatically lower than the trailing P/E of 99.6x, reflecting analyst consensus for EPS to surge from $0.01 to $2.57. This implies the market expects a significant and rapid improvement in profitability, which, if achieved, would justify the current valuation.
- Strategic Multi-Brand Platform via Alani Nu: The acquisition of Alani Nu has successfully transformed Celsius into a multi-brand growth platform, driving record revenue. This diversification mitigates reliance on the core Celsius brand and provides a new engine for growth, as highlighted in recent positive news.
- Strong Strategic Partnership with PepsiCo: The capital-light distribution partnership with PepsiCo provides a significant competitive advantage in shelf space and logistics. PepsiCo's 11% stake aligns its interests with Celsius's success, offering a powerful channel for sustained growth.
- Robust Q4 Revenue Growth of 117% YoY: Despite recent volatility, Q4 2025 revenue of $721.6 million grew 117.2% year-over-year, demonstrating the underlying demand for its products. This explosive growth, even if lumpy, shows the company's market penetration capabilities.
Bearish
- Severe Technical Downtrend and Price Collapse: The stock is down 37.94% over 3 months and 57.05% from its high, trading just 11% above its 52-week low. This deep correction signals a major breakdown in investor confidence and creates significant overhead resistance, with the 52-week high at $66.74.
- Extremely High Trailing P/E of 99.6x: The trailing P/E ratio of 99.6x is exceptionally high, indicating the stock is priced for perfection. This valuation leaves no room for execution missteps and is vulnerable to compression if growth expectations are not met.
- Inconsistent and Volatile Bottom-Line Execution: Profitability is highly erratic, with Q4 2025 net income of $24.7 million following a Q3 2025 net loss of -$61.0 million. This volatility raises serious questions about the sustainability and predictability of earnings.
- Poor Cash Conversion & Working Capital Strain: Despite positive TTM free cash flow, Q4 2025 operating cash flow was -$119.4 million, driven by a $248.0 million build in accounts receivable. This suggests aggressive sales may be coming at the cost of cash collection, impacting financial health.
CELH Technical Analysis
The stock is in a pronounced downtrend, having declined 8.45% over the past year and a severe 37.94% over the last three months. As of the latest close at $33.27, the price is trading near the lower end of its 52-week range, positioned at approximately 11% above the 52-week low of $27.66 and 50% below the 52-week high of $66.74, indicating the stock is in a deep correction and approaching oversold territory. Recent momentum shows a stark divergence; while the 1-month performance shows a modest 1.87% gain, this is against a backdrop of extreme weakness over the 3-month and 6-month periods (-37.94% and -18.73%, respectively), and this minor uptick is likely a bear market rally or consolidation within a larger downtrend, especially given the stock's relative strength versus the S&P 500 has been deeply negative across all measured periods. Key technical levels are clearly defined, with immediate support at the 52-week low of $27.66 and major resistance at the 52-week high of $66.74; a sustained break below support could trigger another leg down, while any recovery would need to contend with significant overhead supply. The stock's beta of 0.935 suggests its volatility is slightly below the market's, but this has not shielded it from severe idiosyncratic selling pressure, as evidenced by a maximum drawdown of -57.05%.
Beta
0.94
0.94x market volatility
Max Drawdown
-57.2%
Largest decline past year
52-Week Range
$27-$67
Price range past year
Annual Return
-30.8%
Cumulative gain past year
| Period | CELH Return | S&P 500 |
|---|---|---|
| 1m | -17.2% | +4.6% |
| 3m | -35.3% | +12.6% |
| 6m | -34.0% | +10.4% |
| 1y | -30.8% | +27.0% |
| ytd | -41.9% | +11.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CELH Fundamental Analysis
Revenue growth has shown significant volatility on a quarterly basis, with the most recent Q4 2025 revenue of $721.6 million representing a robust 117.2% year-over-year increase, but this follows a quarter (Q3 2025) where revenue was essentially flat sequentially at $725.1 million, indicating potential lumpiness or a growth plateau. The company is profitable on a net income basis, reporting $24.7 million in Q4 2025, but this follows a significant net loss of -$61.0 million in Q3 2025, highlighting inconsistent bottom-line execution; gross margin remains healthy at 47.4% for Q4 2025, though it has fluctuated between 47.4% and 52.3% over the last four quarters, reflecting potential input cost or sales mix pressures. The balance sheet and cash flow picture is mixed: the company maintains a solid current ratio of 1.68 and a low debt-to-equity ratio of 0.23, indicating a strong liquidity position and manageable leverage, but trailing twelve-month free cash flow of $323.4 million is overshadowed by a deeply negative operating cash flow of -$119.4 million in Q4 2025, driven by a massive $205.9 million increase in working capital, primarily from a $248.0 million build in accounts receivable, which raises questions about cash conversion and the quality of recent sales.
Quarterly Revenue
$721628000.0B
2025-12
Revenue YoY Growth
+1.17%
YoY Comparison
Gross Margin
+0.47%
Latest Quarter
Free Cash Flow
$323375000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CELH Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE is exceptionally high at 99.6x, while the forward PE is substantially lower at 16.4x, indicating the market is pricing in a massive rebound in earnings, with analyst consensus expecting EPS to surge from $0.01 to $2.57. Compared to sector averages, the stock's trailing PE of 99.6x and Price-to-Sales (PS) ratio of 4.28x are not directly comparable without a provided industry benchmark, but the forward PE of 16.4x suggests the market expects future profitability to align more closely with growth peers once the anticipated earnings materialize. Historically, the stock's own valuation has compressed dramatically; the current trailing PE of 99.6x is below its recent historical highs seen in Q1 2025 (47.2x) and Q2 2024 (42.3x), but remains elevated compared to periods of loss, indicating the market is still assigning a premium for growth expectations despite the recent price collapse, though it is far from its peak optimism.
PE
99.6x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -179x~1784x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
54.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are pronounced, centered on earnings volatility and cash flow quality. The company swung from a $61.0 million net loss in Q3 2025 to a $24.7 million profit in Q4, demonstrating extreme bottom-line inconsistency that makes forecasting difficult. More alarmingly, Q4 operating cash flow was -$119.4 million due to a $248.0 million surge in accounts receivable, indicating sales are not converting to cash efficiently. While the balance sheet shows strength with a 1.68 current ratio and 0.23 debt-to-equity, this working capital drain could pressure liquidity if not reversed, calling into question the sustainability of its growth model.
Market & Competitive Risks are elevated due to valuation compression and intense rivalry. The stock's trailing P/E of 99.6x is extremely high, making it vulnerable to de-rating if growth decelerates or margins disappoint. Recent news specifically cites competition from Costco as a key threat, highlighting the challenges in a crowded energy drink market. Furthermore, the stock's severe underperformance (relative strength of -48.2% vs. SPY over 3 months) suggests it is facing intense idiosyncratic selling pressure, potentially due to sector rotation away from high-multiple growth stories or specific execution concerns.
Worst-Case Scenario involves a failure to meet lofty forward earnings estimates, triggering a valuation collapse. A chain of events where Q3-style losses recur, the Alani Nu integration stumbles, and competitive pressures intensify could lead analysts to slash forward EPS estimates. This would destroy the rationale for the forward P/E of 16.4x, causing multiple compression. The realistic downside could see the stock re-test and break its 52-week low of $27.66, representing a -17% decline from the current $33.27. In a more severe bear case, given the -57% maximum drawdown already experienced, a drop to the mid-$20s (-25% to -30%) is plausible if investor sentiment turns decisively negative.
FAQ
The key risks are, in order of severity: 1) Execution & Earnings Risk: The company's profits are highly volatile (Q3 loss of -$61M vs. Q4 profit of $24.7M), and failure to hit the $2.57 EPS target would crater the stock. 2) Valuation Compression Risk: The high trailing P/E of 99.6x leaves the stock vulnerable to de-rating if growth slows. 3) Financial Quality Risk: Q4 operating cash flow was -$119.4M due to a $248M accounts receivable build, indicating potential issues with sales quality or collection. 4) Competitive Risk: The energy drink market is fiercely competitive, with recent news highlighting pressure from giants like Costco.
The 12-month forecast is highly bifurcated with three scenarios. The Base Case (50% probability) sees the stock trading between $35 and $50 as it delivers choppy growth roughly in line with EPS estimates. The Bull Case (25% probability) could drive the stock to $55-$67 on flawless execution and restored confidence. The Bear Case (25% probability) risks a drop to $25-$32 if earnings miss and the valuation compresses. The most likely outcome is the base case, as it acknowledges the company's promising assets but also its recent history of volatility and the stock's severe technical damage.
CELH's valuation is a tale of two metrics, making it fairly valued for its risk profile. Based on trailing earnings, it is extremely overvalued with a P/E of 99.6x. However, based on forward analyst estimates, it appears reasonably valued at a P/E of 16.4x. This dichotomy means the market is paying a fair price for the expectation of massive future profits. The valuation implies the market expects flawless execution and the successful realization of the Alani Nu acquisition's benefits. Any stumble will cause this forward multiple to expand rapidly, revealing overvaluation.
CELH is not a good buy for most investors at this moment, but it represents a high-risk, high-reward opportunity for a specific profile. The stock has crashed 37.94% in three months and trades on the hope of EPS exploding from $0.01 to $2.57, justifying its forward P/E of 16.4x. The downside risk to the 52-week low of $27.66 is -17%, with potential for further declines if earnings disappoint. It could be a good buy for very patient, risk-tolerant investors who believe in the multi-brand strategy and are willing to wait through volatility, but it requires a strong stomach and should only be a small position.
CELH is unsuitable for short-term trading due to its high volatility (beta 0.935, but with -57% max drawdown) and current downtrend. It is only appropriate for a long-term investment horizon of 3-5 years, and only for investors who can withstand significant interim losses. The long-term thesis depends on the multi-brand platform maturing and delivering sustained profitability, which will take several quarters to prove. There is no dividend to provide income during the wait. The minimum suggested holding period is 12-18 months to assess whether the forward earnings projections are being met.